Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
MDR-001 in Overweight or Obesity
NCT07110766Phase 1Not yet recruiting
- Sponsor
- MindRank
- Start
- Aug 2025
- Primary completion
- Sep 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, double-blind trial in obesity and Overweight comparing MDR-001 with Placebo (2 arms). Primary endpoint: Percent Change in Body Weight From Baseline at Week 12. Planned start Aug 2025; status: not yet recruiting.
02
Drugs
MDR-001
03
Conditions
obesityOverweight
Beyond the preview
Go deeper on NCT07110766.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07110766.